Cardiopulmonary Bypass Equipment Market to Grow at a CAGR of ~4.14% by 2032 | DelveInsight

The cardiopulmonary bypass equipment market is witnessing positive growth driven by several key factors, including the increasing prevalence of cardiovascular diseases, a growing aging population, rising number of open-heart and other cardiac surgeries, and continuous advancements in surgical and perfusion technologies. As a result, the cardiopulmonary bypass equipment market is expected to expand steadily between 2025 and 2032.
DelveInsight's Cardiopulmonary Bypass Equipment Market Insights [https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr] report provides the current and forecast market analysis, individual leading cardiopulmonary bypass equipment companies' market shares, challenges, cardiopulmonary bypass equipment market drivers, barriers, and trends, and key cardiopulmonary bypass equipment companies in the market.

Key Takeaways from the Cardiopulmonary Bypass Equipment Market Report

- The cardiopulmonary bypass equipment market was valued at USD 405.18 million in 2023 and is expected to reach USD 516.82 million by 2032, growing at a CAGR of 4.14% during the forecast period.

- As per DelveInsight estimates, North America is anticipated to dominate the global cardiopulmonary bypass equipment market during the forecast period.

- Notable cardiopulmonary bypass equipment companies such as Medtronic plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG, ABIOMED, Braile Biomedica Ltda, Tianjin Medical, Terumo Corp, Senko Medical Instrument Manufacturing Co., Ltd., Technowood Corp, Sorin, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, OriGen Biomedical, Thoratec Corporation, Inspira Technologies OXY B.H.N. Ltd., Boston Scientific, Cardinal Health, B. Braun, and several others are currently operating in the cardiopulmonary bypass equipment market.

- In May 2024, Terumo Corporation, a global leader in cardiovascular surgery technologies, announced that the FDA had granted 510(k) clearance for the CDI OneView Monitoring System. This next-generation CDI Systems platform provided enhanced visibility of key patient parameters during cardiopulmonary bypass surgery

- In December 2024, Roivios announced FDA approval of an Investigational Device Exemption (IDE) for its JuxtaFlow Renal Assist Device (RAD), enabling a pivotal trial. The GRADIENT trial aims to improve outcomes for cardiac surgery patients with renal insufficiency, who are at higher risk of complications during cardiopulmonary bypass.

- In May 2023, LivaNova received FDA 510(k) clearance for its Essenz Trademark Heart-Lung Machine (HLM) and launched it in the U.S. The device also gained approvals in Canada and Japan. LivaNova is expanding its commercial release in Europe, offering a data-driven system to improve patient care during cardiopulmonary bypass procedures.

To read more about the latest highlights related to the cardiopulmonary bypass equipment market, get a snapshot of the key highlights entailed in the Global Cardiopulmonary Bypass Equipment Market Report [https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Cardiopulmonary Bypass Equipment Overview

Cardiopulmonary bypass equipment is a critical component in open-heart and other major cardiac surgeries, providing temporary support to the heart and lungs by maintaining blood circulation and oxygenation during procedures. The equipment includes heart-lung machines, oxygenators, pumps, cannulas, and other accessories that work together to divert and return blood to the patient's body while the heart is stopped. Widely used in coronary artery bypass grafting (CABG), valve replacements, and congenital heart defect repairs, cardiopulmonary bypass equipment plays a vital role in ensuring surgical success and patient safety. Ongoing technological advancements in perfusion systems, biocompatible materials, and safety features are enhancing the efficiency, precision, and outcomes of cardiac surgeries, contributing to the steady growth of this market.

Cardiopulmonary Bypass Equipment Market Insights

North America is anticipated to dominate the cardiopulmonary bypass equipment market in 2023, driven by the high prevalence of cardiac and respiratory diseases, increasing awareness through government initiatives and health campaigns, and the strong presence of key market players engaged in product innovation and strategic activities. Conditions such as coronary heart disease, atrial fibrillation, stroke, and COPD often require complex surgical interventions that depend heavily on cardiopulmonary bypass equipment for maintaining circulatory and respiratory function. Additionally, growing public education efforts, such as American Heart Month, and ongoing product advancements-like FDA approvals of new heart-lung machines-are further supporting market growth across the region.

To know more about why North America is leading the market growth in the cardiopulmonary bypass equipment market, get a snapshot of the Cardiopulmonary Bypass Equipment Market Outlook [https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Cardiopulmonary Bypass Equipment Market Dynamics

The Cardiopulmonary Bypass Equipment Market is poised for growth globally, driven by the rising burden of heart and circulatory diseases such as coronary heart disease, atrial fibrillation, and stroke, which often require complex surgical interventions. These procedures rely on cardiopulmonary bypass systems to maintain circulatory and respiratory functions, fueling market demand. Additionally, increasing product development, regulatory approvals, and strategic expansions by key players are further propelling market growth. However, potential complications associated with bypass procedures and stringent regulatory requirements may present challenges to the market's future expansion.

Get a sneak peek at the cardiopulmonary bypass equipment market dynamics @ https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market [https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Coverage: Global

Study Period: 2022 to 2032

Cardiopulmonary Bypass Equipment Market CAGR: ~4.14%

Key Cardiopulmonary Bypass Equipment Companies: Medtronic plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG, ABIOMED, Braile Biomedica Ltda, Tianjin Medical, Terumo Corp, Senko Medical Instrument Manufacturing Co., Ltd., Technowood Corp, Sorin, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, OriGen Biomedical, Thoratec Corporation, Inspira Technologies OXY B.H.N. Ltd., Boston Scientific, Cardinal Health, B. Braun, and others.

Cardiopulmonary Bypass Equipment Market Segmentation

Market Segmentation By Product Type: Heart-Lung Machines, Oxygenators, Autotransfusion Systems, and others.

Market Segmentation By Application: Cardiovascular, Respiratory, Hemodialysis, and others.

Market Segmentation By End User: Hospitals, Specialty Clinics, Dialysis Centers, and Ambulatory Surgery Centers.

Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Which MedTech key players in the cardiopulmonary bypass equipment market are set to emerge as the trendsetter, explore @ Cardiopulmonary Bypass Equipment Companies [https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Table of Contents

1. Electrophysiology Devices Market Report Introduction

2. Electrophysiology Devices Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Electrophysiology Devices Market Key Factors Analysis

6. Electrophysiology Devices Market Porter's Five Forces Analysis

7. Electrophysiology Devices Market Layout

8. Electrophysiology Devices Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cardiopulmonary-bypass-equipment-market-to-grow-at-a-cagr-of-414-by-2032-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.